Latest News and Press Releases
Want to stay updated on the latest news?
-
Crypto.com, a pioneering force, is making waves with its “Level-Up” program, which aims to accelerate the world's transition to cryptocurrency and empower individuals by providing a secure and...
-
Dutch sovereign AI challenger GLBNXT takes on hyperscalers with a privacy-first platform. Dell & NVIDIA-backed, ISO 27001, NIS2, 30-day deploy.
-
Springboards announced the alpha launch of Flint, an AI tool for creatives designed to generate high-variance options and break out of predictable outputs.
-
New Beyond Breakfast Sausage Links and Patties, now made with heart-healthy avocado oil,1 deliver craveable taste, clean ingredients and strong nutrition EL SEGUNDO, Calif., April 13, 2026 (GLOBE...
-
West Bend, WI, April 13, 2026 (GLOBE NEWSWIRE) -- The U.S. Concealed Carry Association (USCCA) today strongly supports Secretary of War Pete Hegseth’s announcement authorizing expanded personal...
-
Nordic American Tankers Ltd (NYSE: NAT) – Chaotic conditions create more transportation work for NAT
Monday, April 13, 2026 Dear Shareholders and Investors, In these chaotic times, many of you ask us about the energy markets and what consequences these may have for our business. First, our main...
-
Rotterdam, The Netherlands (13 April 2026) We are pleased to inform you that IMCD will publish its first three months 2026 results on Thursday 30 April 2026 at 07.00 am CET. Following the...
-
Boehringer Ingelheim introduces LENZELTA®: A new vaccine advancing mastitis prevention in dairy cows
LENZELTA® is a new vaccine significantly reducing the incidence and severity of clinical mastitis in vaccinated cows and heifers1. Administration is simple with two doses during the dry-off...
-
Aalst, Belgium, April 13, 2026 – Ontex Group NV, a leading international developer and producer of personal care products, will share its results for the first quarter of 2026 at 07:00 CEST / 06:00...
-
Sanofi and Regeneron’s Dupixent approved in the EU as the first targeted medicine to treat young children with chronic spontaneous urticaria Approval in CSU for children two to 11 years of age is...